Labcorp Holdings Inc. (LH)
NYSE · Healthcare · Medical - Diagnostics & Research
Profile
Labcorp Holdings Inc.
- Exchange
- NYSE
- Ticker
- LH
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Country
- US
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
Key facts
Labcorp Holdings Inc.: key facts
- Labcorp Holdings Inc. (NYSE: LH) is a Medical - Diagnostics & Research company in the Healthcare sector.
- In fiscal 2025, Labcorp Holdings Inc. reported revenue of $14.0B and net income of $876.5M.
- Revenue grew 1.5% a year over the last 4 fiscal years.
- Free cash flow was positive in 5 of the last 5 fiscal years.
- Net income was positive in 5 of the last 5 fiscal years.
- Over the last twelve months, revenue was $14.6B and net income was $1.0B.
MonkScore
Labcorp Holdings Inc.'s MonkScore
MonkScore
MonkScore range: 50–60
as of October 2026
Sector rank: 301 of 628 in Healthcare
How this score is madeDisclaimer
Pillar ranges
- Growth30–40
- Profitability60–70
- Quality60–70
- Market Conviction60–70
- Safety30–40
The MonkScore runs from 0 to 100. Each range is one of ten 10-point groups, from 0–10 to 90–100.
Each pillar's range uses the same ten groups. The exact score and the pillar scores are in the MonkStreet app.
Fundamentals
Figures from the statements
Labcorp Holdings Inc.'s annual figures and the last twelve months, in USD. Last report: 30 September 2026.
| Figure | Last 12 months | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Revenue | $14.6B | $14.0B | $13.0B | $12.2B | $11.9B | $13.1B |
| Gross profit | $4.1B | $3.7B | $3.6B | $3.4B | $3.7B | $5.0B |
| Operating income | $1.6B | $1.5B | $1.1B | $725.6M | $1.4B | $3.0B |
| Net income | $1.0B | $876.5M | $746.0M | $418.0M | $1.3B | $2.4B |
| Operating cash flow | $1.8B | $1.6B | $1.6B | $1.3B | $2.0B | $3.1B |
| Capital expenditure | -$528.1M | -$434.5M | -$489.9M | -$453.6M | -$481.9M | -$460.4M |
| Free cash flow | $1.3B | $1.2B | $1.1B | $874.1M | $1.5B | $2.6B |
| Total debt | $6.8B | $7.2B | $7.3B | $6.0B | $6.2B | $6.3B |
| Cash | $261.8M | $532.3M | $1.5B | $536.8M | $320.6M | $1.5B |
Revenue growth a year
- 1-year
- 7.2%
- 3-year
- 5.6%
- 4-year
- 1.5%
Compound growth between fiscal years.
Peers
Similar companies
- Waters CorporationNYSE:WATMonkScore range: 60–70
- Thermo Fisher Scientific Inc.NYSE:TMOMonkScore range: 60–70
- Natera, Inc.NASDAQ:NTRAMonkScore range: 70–80
- Quest Diagnostics IncorporatedNYSE:DGXMonkScore range: 70–80
- Sotera Health CompanyNASDAQ:SHCMonkScore range: 70–80
- IQVIA Holdings Inc.NYSE:IQVMonkScore range: 70–80
- Agilent Technologies, Inc.NYSE:AMonkScore range: 70–80
- Mettler-Toledo International Inc.NYSE:MTDMonkScore range: 90–100
Compare
Compare with
Score my top stocks · 14-day free trial · card required · not charged during the trial · cancel in one click
MonkStreet provides research, not investment advice.
Page built on 31 October 2026.